Computational Biology Market to Grow with a CAGR of 7.49% through 2028
Technological innovations, data-driven research, and
the increasing importance of biological insights in various industries is
expected to drive the Global Computational Biology Market growth in the
forecast period, 2024-2028.
According to TechSci Research report, “Computational
Biology Market – Global Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2028”, the Global Computational Biology Market stood at
USD 4.89 billion in 2022 and is anticipated to grow with a CAGR of 7.49% in
the forecast period, 2024-2028. This can be attributed to emerging technologies.
Emerging technologies, such as single-cell sequencing, spatial transcriptomics,
and multi-omics integration, are expanding the horizons of computational
biology. These technologies offer new dimensions for studying complex
biological systems, enabling deeper insights and driving the demand for advanced
computational tools.
Moreover, the CRISPR-Cas9 gene-editing technology
continues to advance, enabling precise genetic modifications. Computational
biology will play a role in designing and optimizing CRISPR experiments and
analyzing the resulting genomic data. Expect advancements in CRISPR-related
computational tools and methodologies.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Computational Biology Market.”
The computational biology market has been influenced
by the COVID-19 pandemic in various ways. Apart from expediting the
understanding of the genome, protein structure, variants, mutations, and other
biological facets of SARS-CoV-2, computational biology has proven valuable in
several other aspects. It aids in uncovering evidence about the virus's origin,
host, and evolutionary path through bioinformatics analysis. Additionally,
techniques like molecular docking, molecular dynamics simulations, and artificial
intelligence (AI) can expedite the discovery of novel medications. For example,
a review article published in March 2021, titled 'Computational strategies to
combat COVID-19: useful tools to accelerate SARS-CoV-2 and coronavirus
research,' highlighted the ARTIC network's expertise in utilizing nanopore
sequencing technology for sequencing and monitoring outbreaks, including Zika
and Ebola. Nanopore sequencing is employed to rapidly generate highly accurate
SARS-CoV-2 genomes and monitor COVID-19 transmission and viral evolution.
Several factors are responsible for driving market
growth, including an upsurge in bioinformatics research, a growing number of
clinical studies in pharmacogenomics and pharmacokinetics, and the expansion of
drug design and disease modeling. Bioinformatics has become an integral part of
the knowledge base for numerous careers in biomedical research and healthcare.
Over the past 15 years, the field of bioinformatics and computational biology
has undergone significant transformations, establishing itself as a crucial
component of modern biology. For instance, according to updates from the
Department of Biotechnology (DBT) in February 2022, the proliferation of
sequence databases resulting from genome sequencing initiatives has heightened
the demand for bioinformatics tools and knowledge. Data mining, a subfield of
bioinformatics, utilizes big data analysis to identify trends and extract
significant, non-obvious, implicit, previously unknown, and potentially
relevant information. The rising research activities in computational biology
are anticipated to propel market growth in the foreseeable future.
Moreover, in March 2022, Compugen Ltd., an
Israeli-based clinical-stage cancer immunotherapy company, presented at the
Keystone Symposium on Cancer Immunotherapy. They discussed their exploration of
the Immune-Tumor Microenvironment (TME) using high-resolution single-cell
spatial transcriptomics. The presentation showcased Compugen's use of
high-resolution single-cell spatial mapping to decipher the intricate TME and
their extensive expertise in computational immuno-oncology biology. Their
advanced technology provides insights into the composition and spatial
arrangement of individual cells in the TME.
Recent advancements in bioinformatics have been
facilitated by capacity-building efforts, including research funding and
training opportunities. Increased funding in the field of bioinformatics is
fostering progress in computational biology. For example, in July 2022, Adrian
Woolfson, a former executive at Pfizer and Bristol-Myers Squibb, announced a
substantial seed funding of USD 55 million to advance genomic products and
reprogram biology. Consequently, the increased research funding from
bioinformatics is expected to drive the growth of the computational biology
market in the coming years.
However, a significant impediment to market growth is
the shortage of adequately trained professionals.
The Global Computational Biology Market is segmented
into application, tool, service, end user, regional distribution, and company.
Based on its application, the cellular &
biological simulation segment emerged as the leading revenue contributor in the
market. This can be attributed to the growing demand for open-source software
for simulating virtual cells, as well as the utilization of computer genomics
and computational proteomics. Furthermore, numerous private and commercial
cloud platforms collaborate with governmental and public entities to offer
cellular & biological simulation services, which is expected to stimulate
market growth.
The drug discovery & disease modeling segment is
projected to experience the most rapid growth during the computational biology
market's forecast period. This growth is driven by the increasing number of
drug development initiatives and a rising awareness of target selection
methods, including assays and readers, as well as automation and high-content
screening techniques.
Based on end user, the commercial sector emerged as
the top revenue generator in the market. This can be attributed to the
escalating investments in Research and Development (R&D) related to genetic
engineering and the discovery of new drugs, both by public and private
companies. These investments significantly contribute to the surging demand for
computational biology.
Conversely, the academic & research segment is
experiencing the most rapid growth during the forecast period. This growth is
driven by the increasing emphasis on drug discovery and disease modeling for
various chronic conditions like cancer, diabetes, cardiovascular diseases, and
respiratory disorders. These factors create a substantial demand for this
segment, further boosted by the increasing need for predictive models and their
utilization in population-based sequencing projects, such as the Human Genome
Project. Additionally, government funding plays a pivotal role in propelling
the growth of the computational biology market.
Major companies operating in
Global Computational Biology Market are:
- Dassault Systemes SE
- Certara Inc
- Chemical Computing Group ULC
- Compugen Ltd
- Rosa & Co. LLC
- GeneData AG
- Insilico Biotechnology AG
- Instem PLC
- Strand Life Sciences Pvt Ltd
- Schrodinger Inc
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global Computational Biology Market is poised for
a dynamic future characterized by innovation and transformative trends. As
technology and research methodologies evolve, computational biology will remain
at the forefront of scientific discovery, drug development, and personalized
medicine. Staying abreast of the upcoming trends will be essential for
researchers, organizations, and industry players to harness the full potential
of computational biology in shaping the future of healthcare and life sciences,”
said Mr. Karan Chechi, Research Director with TechSci Research, a
research-based management consulting firm.
“Computational Biology Market By
Application (Cellular and Biological Simulation,
Drug Discovery and Disease Modelling, Preclinical Drug Development, Clinical
Trials, Human Body Simulation Software), By Tool (Databases, Infrastructure
(Hardware), Analysis Software and Services), By Service (In-house, Contract),
By End User (Academics, Industry and Commercials), By Region, By Competition Forecast &
Opportunities, 2018-2028F”, has evaluated the future growth potential of Global
Computational Biology Market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Computational
Biology Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com